Avagliano Mark 4
4 · G1 Therapeutics, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Avagliano Mark
Chief Business Officer
Transactions
- Award
Common Stock
2024-07-01+35,000→ 244,683 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests 50% on July 1, 2025 and 50% on July 1, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 23,223 shares of common stock; (ii) 2,750 RSUs from award granted on January 4, 2021; (iii) 6,000 RSUs from award granted on January 3, 2022; (iv) 15,450 RSUs from award granted on January 3, 2023; (v) 17,500 RSUs from award granted on May 10, 2023; (vi) 44,760 RSUs from award granted on January 3, 2024; (vii) 100,000 RSUs from award granted on March 20, 2024; and (viii) 35,000 RSUs from award granted on July 1, 2024.